MRI-Guided Cryoablation for Focal Native Prostate Cancer
Condition: Primary Malignant Neoplasm of Prostate (Diagnosis)
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT04797039
Sponsor: Mayo Clinic
Phase:
Eligibility:
- Age: minimum 30 Years maximum 100 Years
- Gender: Male
Inclusion Criteria:
- Patients with "biopsy proven" Gleason7 prostate cancer referred to Urology and/or Interventional Radiology for treatment
- Surgery and/or Radiation is not a desirable alternative therapy at the time of enrollment
- Tumor size is < 2 cm at its largest diameter
- Tumor does not encompass the rectal wall or external urethral sphincter
- Patient is able to undergo MRI
Exclusion Criteria:
- •
View trial on ClinicalTrials.gov
{{footer-clinical-trials-navigation}}